Published in Gene Therapy Weekly, April 20th, 2006
L.B.E. Shields and colleagues, University of Louisville, wrote that the study was undertaken as "a retrospective review of patients who underwent an anterior cervical fusion using rhBMP-2 with an absorbable collagen sponge (INFUSE; Medtronic Sofamor Danek, Minneapolis, MN)."
They added, "To ascertain the complication rate after the use of high-dose INFUSE in anterior cervical fusions. The rhBMP-2 has been primarily investigated in lumbar spine...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.